Dr. Gabriel Rendon, MD

Dr. Rendon practices at Texas Endoscopy at Independence Medical Village in Plano, Texas.

Dr. Rendon's NPI, 1235161761, was assigned on July 7, 2006. Dr. Rendon graduated from UT Southwestern Medical Center in 2004. Dr. Rendon holds Texas license M8948.

Dr. Rendon's primary practice is Texas Endoscopy at Independence Medical Village, at 8080 Independence Parkway Suite160, Plano, TX 75025. The practice phone is (972) 908-3000.

Dr. Rendon's primary practice is Texas Endoscopy at Independence Medical Village in Plano, Texas. Dr. Rendon is also affiliated with Baylor Scott & White Medical Center - McKinney. The medical group on file is Texas Digestive Disease Consultants. Dmand AI also links Dr. Rendon to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rendon practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rendon's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Rendon is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Rendon's licenses on file in 2 states: Texas and Massachusetts.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Rendon treats.

CMS data shows 336 Medicare services from Dr. Rendon across 11 procedure codes in 2024, for 291 Medicare patients. Medicare paid $40,629 for them.

CMS counts 291 Medicare patients who saw Dr. Rendon in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rendon's median patient age at 58, with 46% women.

In 2024, Dr. Rendon wrote 624 Medicare Part D claims for 265 patients. 62% of them were for generic drugs. CMS names the drug for 474 of them, across 16 drugs with 11 or more claims each, at $621,331 in total drug cost. In 2023, CMS named 490 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Rendon for performance year 2024, reported as part of a group. Dr. Rendon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 125 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rendon, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Rendon, published from 2009 to 2014. Dr. Rendon's most frequent co-authors are Bincy Paulose Abraham, MD, Donna J. Lager, MD and Matthew Lewin, MD.

CMS Open Payments shows 998 general payments to Dr. Rendon from 50 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Abbvie Inc. paid the most, $31,445.

Dmand AI lists 1 award for Dr. Rendon, most recently CMS Stage 1 2012 in 2012.

Dr. Rendon graduated from UT Southwestern Medical Center in 2004. Dr. Rendon is a member of ACG.

Dr. Rendon is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.